Differential in vivo activation of monocyte subsets during low-grade inflammation through experimental endotoxemia in humans.
about
In Vivo Murine-Matured Human CD3+ Cells as a Preclinical Model for T Cell-Based Immunotherapies.Change in gut microbiota is correlated with alterations in the surface molecule expression of monocytes after Roux-en-Y gastric bypass surgery in obese type 2 diabetic patientsIL-1β As Mediator of Resolution That Reprograms Human Peripheral Monocytes toward a Suppressive Phenotype.Increased glucose transporter-1 expression on intermediate monocytes from HIV-infected women with subclinical cardiovascular disease.Involvement of Monocyte Subsets in the Immunopathology of Giant Cell Arteritis.Intermediate CD14++CD16+ monocytes decline after transcatheter aortic valve replacement and correlate with functional capacity and left ventricular systolic function.Guidelines for the use of flow cytometry and cell sorting in immunological studies.Predictors of Subclinical Inflammatory Obesity: Plasma Levels of Leptin, Very Low-Density Lipoprotein Cholesterol and CD14 Expression of CD16+ Monocytes.Patrolling Mechanics of Non-Classical Monocytes in Vascular Inflammation.Role of Monocytes in Heart Failure and Atrial Fibrillation.ERBB signaling attenuates proinflammatory activation of nonclassical monocytes.Differential Interaction of Platelet-Derived Extracellular Vesicles with Leukocyte Subsets in Human Whole Blood.Pro-Inflammatory Th1 and Th17 Cells Are Suppressed During Human Experimental Endotoxemia Whereas Anti-Inflammatory IL-10 Producing T-Cells Are Unaffected.CD86 Expression by Monocytes Influences an Immunomodulatory Profile in Asymptomatic Patients with Chronic Chagas Disease.Altered endotoxin responsiveness in healthy children with Down syndrome
P2860
Q33796950-4674A600-6912-4299-A365-AE64FEE2E2CDQ37733018-FA4547AA-E05B-45D4-A98C-F3FBB76E987BQ40086331-45BA7B9A-DEB6-43D5-A4E1-C9786585FFF5Q40456141-AD174E03-151E-49A3-A0E9-55333EB005E4Q41141307-598E4F12-F431-48F7-8376-9811BA3A76B0Q41501489-8C2B37AA-CCEF-49D1-A859-9EE7452DBB79Q41918189-D1ADC373-05FC-4DD3-AFD7-5C75342EF50CQ47118534-DCEF112B-F292-4E87-ABAF-3EBFF2AA8BBFQ47193091-F4DE8E66-3576-4F44-AAD7-8A48DEE8BDC7Q50119083-C25CF6FA-3F70-455F-BBA5-2D8F2B95E6BCQ51123571-5B400BB3-C2E0-42BF-89E2-A8666CAB0933Q52560150-DD11A231-10EB-4C32-8868-EC686DEE32C3Q55312246-6F26E857-6BAC-43E1-A028-EB92B4095F6CQ55364024-2CC98C3F-3059-49E8-8BA8-4591E6D7BF76Q58613664-7835FE05-7505-4194-B63B-46A73C517BBF
P2860
Differential in vivo activation of monocyte subsets during low-grade inflammation through experimental endotoxemia in humans.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Differential in vivo activatio ...... imental endotoxemia in humans.
@en
Differential in vivo activatio ...... imental endotoxemia in humans.
@nl
type
label
Differential in vivo activatio ...... imental endotoxemia in humans.
@en
Differential in vivo activatio ...... imental endotoxemia in humans.
@nl
prefLabel
Differential in vivo activatio ...... imental endotoxemia in humans.
@en
Differential in vivo activatio ...... imental endotoxemia in humans.
@nl
P2093
P2860
P50
P356
P1433
P1476
Differential in vivo activatio ...... rimental endotoxemia in humans
@en
P2093
P J Hohensinner
P Matzneller
P2860
P2888
P356
10.1038/SREP30162
P407
P577
2016-07-22T00:00:00Z